These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9545110)

  • 1. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
    Hidaka Y; Okumura M; Fukata S; Shimaoka Y; Takeoka K; Tada H; Kuma K; Amino N
    Thyroid; 1999 Feb; 9(2):149-53. PubMed ID: 10090314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
    Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
    Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis.
    Amino N; Hidaka Y; Takano T; Izumi Y; Tatsumi KI; Nakata Y
    Thyroid; 2003 Aug; 13(8):811-4. PubMed ID: 14558923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interferon gamma levels in autoimmune thyroid disease.
    Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
    Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
    J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
    Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
    Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease.
    Hidaka Y; Kimura M; Izumi Y; Takano T; Tatsumi KI; Amino N
    Thyroid; 2003 Feb; 13(2):129-32. PubMed ID: 12699586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of serum interleukin-18 in Graves' disease.
    Miyauchi S; Matsuura B; Onji M
    Thyroid; 2000 Sep; 10(9):815-9. PubMed ID: 11041460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies.
    Iwatani Y; Amino N; Mori H; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1983 Feb; 56(2):251-4. PubMed ID: 6218181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease.
    Covas MI; Esquerda A; García-Rico A; Mahy N
    J Investig Allergol Clin Immunol; 1992; 2(3):131-5. PubMed ID: 1342892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum interleukin-12 in Graves' disease.
    Tamaru M; Matsuura B; Onji M
    Eur J Endocrinol; 1999 Aug; 141(2):111-6. PubMed ID: 10427152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.